Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA.
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study NRG HN001.
View study details on ClinicalTrials.gov
Subjects, 18 y/o and older, with a biopsy proven (from primary lesion and/or lymph nodes) diagnosis of cancer of the nasopharynx.
June 01, 2018